A detailed history of Amarillo National Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Amarillo National Bank holds 2,116 shares of ABBV stock, worth $416,767. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,116
Previous 2,282 7.27%
Holding current value
$416,767
Previous $415,000 12.77%
% of portfolio
0.07%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$154.79 - $180.76 $25,695 - $30,006
-166 Reduced 7.27%
2,116 $362,000
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $84,486 - $95,151
-614 Reduced 21.2%
2,282 $353,000
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $7,553 - $9,399
57 Added 2.01%
2,896 $390,000
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $26,842 - $30,786
200 Added 7.58%
2,839 $381,000
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $3,827 - $4,748
-29 Reduced 1.09%
2,639 $428,000
Q4 2021

Jan 24, 2022

BUY
$107.43 - $135.93 $3,115 - $3,941
29 Added 1.1%
2,668 $361,000
Q1 2021

Apr 22, 2021

BUY
$102.3 - $112.62 $9,207 - $10,135
90 Added 3.53%
2,639 $286,000
Q3 2020

Oct 08, 2020

SELL
$85.91 - $100.83 $40,034 - $46,986
-466 Reduced 15.46%
2,549 $223,000
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $36,831 - $49,286
-502 Reduced 14.27%
3,015 $296,000
Q4 2019

Feb 03, 2020

SELL
$72.13 - $90.25 $7,213 - $9,025
-100 Reduced 2.76%
3,517 $311,000
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $48,305 - $58,077
767 Added 26.91%
3,617 $274,000
Q4 2018

Feb 01, 2019

SELL
$77.85 - $96.01 $11,677 - $14,401
-150 Reduced 5.0%
2,850 $263,000
Q2 2018

Jul 19, 2018

BUY
$89.78 - $106.23 $14,095 - $16,678
157 Added 5.52%
3,000 $278,000
Q1 2018

Apr 24, 2018

BUY
$92.01 - $123.21 $10,305 - $13,799
112 Added 4.1%
2,843 $269,000
Q3 2017

Oct 05, 2017

BUY
$69.85 - $89.22 $190,760 - $243,659
2,731
2,731 $243,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $348B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Amarillo National Bank Portfolio

Follow Amarillo National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amarillo National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amarillo National Bank with notifications on news.